TREM2 Agonistic Antibody Enhances Microglial Clearance of Amyloid-Beta and Restores Synaptic Plasticity
Preclinical and Phase 1 biomarker readouts for novel TREM2-targeted monoclonal antibodies show sustained microglial metabolic reprogramming.
An open-access portal tracking research advances and datasets across Alzheimer’s disease, Parkinson’s disease, and ALS. Aggregating scientific findings and open repositories from Alzforum, bioRxiv, OpenNeuro, DANDI, and Agora.
Preclinical and Phase 1 biomarker readouts for novel TREM2-targeted monoclonal antibodies show sustained microglial metabolic reprogramming.
Multi-center longitudinal real-world evidence study evaluating roving-baseline EDSS trajectories, Relapse-Associated Worsening (RAW) versus PIRA rates, and early anti-CD20 / natalizumab intervention across harmonized international MS registries.
International federated research initiative and containerized query framework allowing participating national MS registries to analyze disease-modifying therapy (DMT) safety, anti-CD20 outcomes, and PIRA progression without transferring identifiable patient data.
GDSI Mock data generator
Official open-source repository and tool for Multiple Sclerosis federated research and data harmonization under MS-DATA-ALLIANCE.
MSDA Toolkit For Federated Registries participating in the COVID19 in MS Global Data Sharing initiative (GDSI)
Official open-source repository and tool for Multiple Sclerosis federated research and data harmonization under MS-DATA-ALLIANCE.
MSDA Toolkit For Federated Registries participating in the COVID19 in MS Global Data Sharing initiative (GDSI)
This portal tracks and synchronizes open CNS data based on the following criteria: